Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Bayer | OncologyBayer | Oncology
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
Bayer | Oncology

Bayer | Oncology

N/A

Last Update: 12/02/2026

View Profile
756/1000Fair

Over the last 20 years, the cancer treatment landscape has seen significant progress. However, there is still much work to be done to help the those living with cancer across the globe. With recent innovations in difficult-to-treat tumors, Bayer is at the forefront of t...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:11
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.hikma.com
767/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Bayer | Oncology

Bayer | Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Bayer | Oncology in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - Bayer | Oncology (X = Date, Y = Severity)

Bayer | Oncology cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Bayer | Oncology

Bayer | Oncology

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between Bayer | Oncology company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between Bayer | Oncology and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Bayer | Oncology and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Bayer | Oncology or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - Bayer | Oncology or Hikma Pharmaceuticals ?
Between Bayer | Oncology and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Bayer | Oncology and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-14776
SUMMARY

A security flaw has been discovered in SourceCodester Onlne Examination & Learning Management System 1.0. Affected by this vulnerability is the function pathinfo of the file /upload_files.php of the component Filename Extension. Performing a manipulation results in unrestricted upload. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks. The name of the affected product appears to have a typo in it.

PUBLISHED
Date2026-07-05
UPDATED
Date2026-07-05
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-14775
SUMMARY

A vulnerability was identified in SourceCodester Onlne Examination & Learning Management System 1.0. Affected is an unknown function of the file /process_lesson.php. Such manipulation of the argument user_id leads to unrestricted upload. The attack may be launched remotely. The exploit is publicly available and might be used. The name of the affected product appears to have a typo in it.

PUBLISHED
Date2026-07-05
UPDATED
Date2026-07-05
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-14774
SUMMARY

A vulnerability was determined in itsourcecode Hospital Management System 1.0. This impacts an unknown function of the file /paymentdischarge.php. This manipulation of the argument patientid causes sql injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized.

PUBLISHED
Date2026-07-05
UPDATED
Date2026-07-05
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-14773
SUMMARY

A vulnerability was found in itsourcecode Hospital Management System 1.0. This affects an unknown function of the file /payment.php. The manipulation of the argument patientid results in sql injection. The attack can be launched remotely. The exploit has been made public and could be used.

PUBLISHED
Date2026-07-05
UPDATED
Date2026-07-05
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-10657
SUMMARY

Zephyr's DNS resolver detects mDNS (.local) queries in dns_resolve_name_internal() (subsys/net/lib/dns/resolve.c) with memcmp(strrchr(query, '.'), ".local", 7), which always reads a fixed 7 bytes from the suffix pointer. When the resolved hostname's final label is shorter than 7 bytes (e.g. names ending in .org, .com, .net, .io, or a trailing dot), the comparison reads 1-2 bytes past the string's NUL terminator. The hostname (query) is the caller-supplied name passed through the standard getaddrinfo()/dns_get_addr_info()/dns_resolve_name() path and is influenceable by operators or remote inputs (server names from configuration, parsed URLs, or app-facing interfaces). On a tightly-sized buffer with no slack (for example a userspace getaddrinfo call where the hostname is copied with k_usermode_string_alloc_copy to exactly strlen+1 bytes), the over-read crosses the allocation boundary; if that boundary is unmapped (guard page, memory-domain boundary under MPU, or an address sanitizer) the over-read faults, causing a denial of service. The over-read bytes are never returned, so there is no information disclosure. The flaw is compiled only when CONFIG_MDNS_RESOLVER is enabled, exists since v1.10.0, and is fixed by replacing the fixed-length memcmp with a NUL-safe strcmp(ptr, ".local").

PUBLISHED
Date2026-07-05
UPDATED
Date2026-07-05
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L
IMPACT SCORE
1.4
EXPLOITABILITY
2.2